CH IDMP (R5) - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Home
Official URL : http://fhir.ch/ig/ch-idmp/ImplementationGuide/ch.fhir.ig.ch-idmp
Version :
1.0.0-ballot
Active
as of 2025-12-08
Computable Name : CH_IDMP
Copyright/Legal : CC0-1.0
Introduction
CH IDMP is a project of the Refdata Foundation Switzerland to enable stuctured datacommunication of medicinal product information in IDMP/FHIR.
This is a draft implementation guide as basis for the first IDMP pilot project planned for the year 2027.
FHIR resources for IDMP
This implementation guide uses the following FHIR resource to represent the context of the international ISO IDMP (Identification of Medicinal Products) standard:
This implementation guide is dependent on
which describe the international context, especially related to IDMP.
Documentation
This implementation guide describes mainly the exchange formats for the Swiss IDMP Pilot Project.
The following documents have been defined (and described in more detail on the respective subsections):
FOPH ePL : Description and summary of the scope ePL project of FOPH (Federal Office of Public Health)
HL7 FHIR Standard : Short description and explanation of the FHIR standard.
ISO IDMP Standard (ISO 11615) : Introduction into the IDMP standard of ISO.
IDMP and FHIR : Explanation on how IDMP is build in FHIR.
The IDMP implentations
Swiss IDMP Implementation : Overview of the IDMP implementation in Switzerland
EMA IDMP Implementation : Introduction of the IDMP implemantation by the European Medicines Agency for the European Union.
Swissmedic IDMP Implementation : Introduction of the IDMP implementation by Swissmedic for Switzerland
Changelog with significant changes, open and closed issues.
Download : You can download this implementation guide in the npm format from here .
Download : You can download this implementation guide as an htmp zip]from here .
Collaboration
This guide is the product of collaborative work undertaken with participants from:
IP Statements
This document is licensed under Creative Commons "No Rights Reserved" (CC0 ).
HL7®, HEALTH LEVEL SEVEN®, FHIR® and the FHIR ® are trademarks owned by Health Level Seven International, registered with the United States Patent and Trademark Office.
This publication includes IP covered under the following statements.
CC0-1.0 Show Usage
CH Refdata - Marketing Status : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 8 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPPackagedProductDefinition , ChRefdataMarketingStatusVS , PackagedProductDefinition/PMP-Comprehensive-Sample-Combipack , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-20-Powder , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-30-Powder and PackagedProductDefinition/PMP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet
CH SMC - MedicinalProductCategory : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 7 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , ChSMCMedicinalProductCategoryVS , MedicinalProductDefinition/Comprehensive-Sample-Combipack , MedicinalProductDefinition/Padcev-20mg-Powder , MedicinalProductDefinition/Padcev-30mg-Powder and MedicinalProductDefinition/Xospata-Filmcoatedtablet
CH SMC - Additional Monitoring Indicator : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 8 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPMedicinalProductDefinition , ChSMCAdditionalMonitoringIndicatorVS , MedicinalProductDefinition/Comprehensive-Sample-Combipack , MedicinalProductDefinition/Padcev-20mg-Powder , MedicinalProductDefinition/Padcev-30mg-Powder and MedicinalProductDefinition/Xospata-Filmcoatedtablet
CH SMC - Attached Document Type : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 9 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPDocumentReference , ChSMCAttachedDocumentTypeVS , DocumentReference/DocRef-FI-Comprehensive , DocumentReference/DocRef-FI-Padcev , DocumentReference/DocRef-FI-Xospata , DocumentReference/DocRef-PI-Comprehensive and DocumentReference/DocRef-PI-Xospata
CH SMC - Authorisation Category : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 5 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , ChSMCAuthorisationCategoryVS , MedicinalProductDefinition/Comprehensive-Sample-Combipack , MedicinalProductDefinition/Padcev-20mg-Powder and MedicinalProductDefinition/Padcev-30mg-Powder
CH SMC - Authorisation Status : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 12 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPRegulatedAuthorization , ChSMCAuthorisationStatusVS , RegulatedAuthorization/MA-123456002 , RegulatedAuthorization/MA-12345601 , RegulatedAuthorization/MA-67211001 , RegulatedAuthorization/MA-6721101 , RegulatedAuthorization/MA-68291001 , RegulatedAuthorization/MA-68291002 , RegulatedAuthorization/MA-6829103 and RegulatedAuthorization/MA-6829104
CH SMC - Ingredient Role : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 4 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPIngredient and ChSMCIngredientRoleVS
CH SMC - Legal Status of Supply : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 11 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , ChSMCLegalStatusOfSupplyVS , MedicinalProductDefinition/Comprehensive-Sample-Combipack , MedicinalProductDefinition/Padcev-20mg-Powder , MedicinalProductDefinition/Padcev-30mg-Powder , MedicinalProductDefinition/Xospata-Filmcoatedtablet , PackagedProductDefinition/PMP-Comprehensive-Sample-Combipack , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-20-Powder , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-30-Powder and PackagedProductDefinition/PMP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet
CH SMC - Marketing Status : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 8 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPMedicinalProductDefinition , ChSMCMarketingStatusVS , MedicinalProductDefinition/Comprehensive-Sample-Combipack , MedicinalProductDefinition/Padcev-20mg-Powder , MedicinalProductDefinition/Padcev-30mg-Powder and MedicinalProductDefinition/Xospata-Filmcoatedtablet
CH SMC - Pediatric Use Indicator : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 8 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPMedicinalProductDefinition , ChSMCPediatricUseIndicatorVS , MedicinalProductDefinition/Comprehensive-Sample-Combipack , MedicinalProductDefinition/Padcev-20mg-Powder , MedicinalProductDefinition/Padcev-30mg-Powder and MedicinalProductDefinition/Xospata-Filmcoatedtablet
CH SMC - Special Precautions for Storage : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 8 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPPackagedProductDefinition , ChSMCSpecialPrecautionsForStorageVS , PackagedProductDefinition/PMP-Comprehensive-Sample-Combipack , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-20-Powder , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-30-Powder and PackagedProductDefinition/PMP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet
CH SMC - Substance : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 4 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPIngredient and ChSMCSubstanceVS
CH - Authorisation Type : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 12 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPRegulatedAuthorization , ChAuthorisationTypeVS , RegulatedAuthorization/MA-123456002 , RegulatedAuthorization/MA-12345601 , RegulatedAuthorization/MA-67211001 , RegulatedAuthorization/MA-6721101 , RegulatedAuthorization/MA-68291001 , RegulatedAuthorization/MA-68291002 , RegulatedAuthorization/MA-6829103 and RegulatedAuthorization/MA-6829104
CH - Medicinal Product Name Type : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , ChMedicinalProductNameTypeVS and MedicinalProductDefinition/Comprehensive-Sample-Combipack
CH - Other Characteristics Type : ChOtherCharacteristicsTypeVS
EMA - Domain : CHIDMPMedicinalProductDefinition and EMADomainVS
EMA - Shelf Life Type : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 7 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , EMAShelfLifeTypeVS , PackagedProductDefinition/PMP-Comprehensive-Sample-Combipack , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-20-Powder , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-30-Powder and PackagedProductDefinition/PMP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet
EMA - Intended Effect : Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b ... Show 15 more , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPClinicalUseDefinitionIndication , ClinicalUseDefinition/IND-10004055 , ClinicalUseDefinition/IND-10046950 , ClinicalUseDefinition/IND-10046961 , ClinicalUseDefinition/IND-10050348 , ClinicalUseDefinition/IND-10057352 , ClinicalUseDefinition/IND-10059034 , ClinicalUseDefinition/IND-10060558 , ClinicalUseDefinition/IND-10079528 , ClinicalUseDefinition/IND-10081513 , ClinicalUseDefinition/IND-10081514 , ClinicalUseDefinition/IND-10084619 and EMAIntendedEffectVS
EDQM - Standard Terms : AdministrableProductDefinition/PhP-Comprehensive-Sample-VaginalCream , AdministrableProductDefinition/PhP-Comprehensive-Sample-VaginalPessary ... Show 31 more , AdministrableProductDefinition/PhP-Enfortumabum-vedotinum-20-Solution , AdministrableProductDefinition/PhP-Enfortumabum-vedotinum-30-Solution , AdministrableProductDefinition/PhP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet , Bundle/200f39aa-ddd8-48a2-a05e-8e4b4e6ac847 , Bundle/52ae1101-1e39-4280-b6dc-b505d7501b2b , Bundle/a058182b-13dc-4797-9364-2cdb9a4c2bd4 , Bundle/ab55cf13-a819-4875-adaa-5545e2cbdddf , CHIDMPAdministrableProductDefinition , CHIDMPManufacturedItemDefinition , CHIDMPMedicinalProductDefinition , CHIDMPPackagedProductDefinition , EdqmCombinationPackagingVS , EdqmCombinedPharmaceuticalDoseFormVS , EdqmCombinedTermVS , EdqmPackagingVS , EdqmPharmaceuticalDoseFormVS , EdqmRouteOfAdministrationVS , EdqmUnitOfPresentationVS , ManufacturedItemDefinition/MI-Comprehensive-Sample-VaginalCream , ManufacturedItemDefinition/MI-Comprehensive-Sample-VaginalPessary , ManufacturedItemDefinition/MI-Enfortumabum-vedotinum-20-Powder , ManufacturedItemDefinition/MI-Enfortumabum-vedotinum-30-Powder , ManufacturedItemDefinition/MI-Gilteritinibi-hemifumaras-40-Filmcoatedtablet , MedicinalProductDefinition/Comprehensive-Sample-Combipack , MedicinalProductDefinition/Padcev-20mg-Powder , MedicinalProductDefinition/Padcev-30mg-Powder , MedicinalProductDefinition/Xospata-Filmcoatedtablet , PackagedProductDefinition/PMP-Comprehensive-Sample-Combipack , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-20-Powder , PackagedProductDefinition/PMP-Enfortumabum-vedotinum-30-Powder and PackagedProductDefinition/PMP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet
This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed or info@snomed.org . Show Usage
WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway. Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed. Show Usage
Cross Version Analysis
This IG can only be used with FHIR R5 systems.
Dependency Table
Package hl7.fhir.uv.extensions.r5#5.2.0
This IG defines the global extensions - the ones defined for everyone. These extensions are always in scope wherever FHIR is being used (built Mon, Feb 10, 2025 21:45+1100+11:00)
Package hl7.fhir.uv.extensions.r5#5.3.0
This IG defines the global extensions - the ones defined for everyone. These extensions are always in scope wherever FHIR is being used (built Sat, May 16, 2026 18:32+1000+10:00)
Package hl7.fhir.uv.tools.r5#1.1.2
This IG defines the extensions that the tools use internally. Some of these extensions are content that are being evaluated for elevation into the main spec, and others are tooling concerns (built Tue, Mar 24, 2026 11:13+1100+11:00)
CH-IDMP currently has no dependency on ch-core, as ch-core is based on FHIR R4, whereas CH-IDMP is based on R5. The use of R5 was necessary because IDMP support is only available from R5 onwards.
Globals Table
There are no Global profiles defined